WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A COMPARATIVE STUDY OF THE EFFICACY OF VAITARANA BASTI AND ERANDAMOOLADI BASTI IN THE MANAGEMENT OF AMAVATA – A STUDY PROTOCOL

Rajiv Birwal* and Ashish Mehta

.

Abstract

Background: Amavata is the common type of problem the present world is facing. Amavata is made up of two words, Ama and Vata, means the incomplete digestion of food which results in incomplete formation of amarasa which circulates in all over the body and approaches in the target cells and which produces the pathology like pain, swelling, stiffness of joints and fever and general debility. Even though this disease is not life threatening but it hampers the daily activity of person. Amavata is a particular type of disease mentioned in Ayurveda since the period of (16th cent. A.D) under the category of vata kapha disorders. Nidanas of Amavata explained by Acharya Madhavakara are viruddh aahara, viruddha chesta, mandagni and exercises after snigdha ahara etc. Whereas treatment of Amavata was first explained by Acharya Chakra Datta. Aim and Objectives: To study the comparative effect of Vaitarana Basti and Erandamooladi Basti in Amavata and to compare the effect of Vaitarana Basti and Erandamooladi Basti on RA factor, E.S.R., Sr. Uric Acid and Anti- CCP. Methodology: We will plan the 60 patients which will be divided randomly into two groups (30 in each). Group A- Vaitarana Kala Basti 960 ml will administer for 16 days and Group B- Erandamooladi Kala Basti 960 ml will administer for 16 days. Results: Changes will be observed in subjective and objective parameters. Conclusion: Vaitarana Basti and Erandamooladi Basti will reduce the symptoms of Amavata and will be lowering the RA factor, E.S.R., Sr. Uric Acid and Anti- CCP level.

Keywords: Vaitarana, Erandamool, Kalabasti, Amavata, Ricinus Communis, Rheumatoid Arthritis.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More